Prothena Corp Public (PRTA) FCF Margin Growth (3y) (2016 - 2026)
Prothena Corp Public (PRTA) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Prothena Corp Public |
479.08 Mn |
149.61 Mn |
- |
224,675.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
224,675.00 |
| Dec 31, 2025 |
-11.10 Mn |
| Sep 30, 2025 |
38,296.00 |
| Jun 30, 2025 |
164,964.00 |
| Mar 31, 2025 |
135,848.00 |
| Dec 31, 2024 |
-30,881.00 |
| Sep 30, 2024 |
-473,968.00 |
| Jun 30, 2024 |
-4,898.00 |
| Mar 31, 2024 |
-12.52 Mn |
| Dec 31, 2023 |
-1.13 Mn |
| Sep 30, 2023 |
1.24 Mn |
| Jun 30, 2023 |
847,475.00 |
| Mar 31, 2023 |
1.43 Mn |
| Dec 31, 2022 |
569,051.00 |
| Sep 30, 2022 |
242,082.00 |
| Jun 30, 2022 |
458,862.00 |
| Mar 31, 2022 |
619,716.00 |
| Dec 31, 2021 |
969,987.00 |
| Sep 30, 2021 |
1.33 Mn |
| Jun 30, 2021 |
-2.07 Mn |
